Update on Genetic Susceptibility and Pathogenesis in Juvenile Idiopathic Arthritis

Update on Genetic Susceptibility and Pathogenesis in Juvenile Idiopathic Arthritis

July 25, 2014 at 9:25 AM 0 comments

Morten Herlin,1,2 Michael B. Petersen,1,2 *Troels Herlin3 1. Department of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark 2. Department of Clinical Medicine, Aalborg University, Aalborg, Denmark 3. Pediatric Rheumatology Clinic, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark *Correspondence to troeherl@rm.dk Disclosure: No potential conflict of interest. Received: 04.04.14 Accepted:Read More

The Importance of the mTOR Regulatory Network in Chondrocyte Biology and Osteoarthritis

The Importance of the mTOR Regulatory Network in Chondrocyte Biology and Osteoarthritis

July 25, 2014 at 9:21 AM 0 comments

*Elena V. Tchetina Senior Scientist, Clinical Immunology Laboratory, Nasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, Russia *Correspondence to etchetina@mail.ru Disclosure: The author has no conflict of interest. Received: 27.03.14 Accepted: 12.05.14 Citation: EMJ Rheumatol. 2014;1:84-95. Abstract Osteoarthritis (OA) is a chronic disorder associated mainly with pain,Read More

Why Basic Calcium Phosphate Crystals Should Be Targeted In the Treatment of Osteoarthritis

Why Basic Calcium Phosphate Crystals Should Be Targeted In the Treatment of Osteoarthritis

July 25, 2014 at 9:19 AM 0 comments

Claire-Louise Murphy, *Geraldine M. McCarthy Mater Misericordiae University Hospital, Department of Rheumatology, Dublin, Ireland *Correspondence to g.mccarthy@ucd.ie Disclosure: Neither of the authors have any conflict of interest. Received: 04.04.14 Accepted: 09.05.14 Citation: EMJ Rheumatol. 2014;1:96-102. Abstract Osteoarthritis (OA) is the most common form of arthritis and results in significant social,Read More

Extra-Articular Manifestations of Rheumatoid Arthritis, Now

Extra-Articular Manifestations of Rheumatoid Arthritis, Now

July 25, 2014 at 9:16 AM 0 comments

*Paloma Vela Section of Rheumatology, Hospital General University of Alicante; Department of Medicine, Miguel Hernández de Elche University, Alicante, Spain *Correspondence to palomavela62@gmail.com Disclosure: The author has received honoraria for lectures from Abbvie, Pfizer, Roche, Bristol-Myers Squibb, MSD, Lilly and UCB, and honoraria for participation in advisory boards from Roche,Read More

Antiphospholipid Syndrome Novel Therapies

Antiphospholipid Syndrome Novel Therapies

July 25, 2014 at 9:14 AM 0 comments

Mohamad Bittar, *Imad Uthman Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon *Correspondence to iuthman@aub.edu.lb Disclosure: No potential conflict of interest Received: 13.03.14 Accepted: 12.05.14 Citation: EMJ Rheumatol. 2014;1:113-121. Abstract Antiphospholipid syndrome (APS) is an autoimmune disease characterised by arterial and/or venous thrombosis, recurrent pregnancy loss,Read More